Strategic upgrade: from framework cooperation to equity binding, build a deep collaborative ecology New Century and Asiatic have a long-standing history of collaboration. In July 2023, the two parties entered into a Strategic Cooperation Framework Agreement, focusing on complementary transportation services, joint market expansion, and resource sharing. The goal of this partnership was to build an integrated "global- regional" logistics network. The proposed acquisition of 51% equity in Asiatic represents a ...

Nexans inaugurates Stella Nova and unveils a world-first demonstration for the electrification of data hall infrastructures in data centers PRESS RELEASE Hanover, June 4, 2025 – At a time when digital infrastructures and sustainability challenges are reshaping the global energy landscape, Nexans is investing to meet tomorrow's critical demands. Today, Nexans inaugurates Stella Nova, its new Center of Excellence located in Hanover, Germany. On this occasion, the Group also unveils a world-first demonstration ...

KALMAR CORPORATION, PRESS RELEASE, 4 JUNE 2025 AT 14:00 PM (EEST) Kalmar and Hanseatic Global Terminals seal significant order for hybrid straddle carriers for CNMP Le Havre terminal Kalmar has signed an agreement with Hanseatic Global Terminals (HGT) to supply 14 Kalmar hybrid straddle carriers for the company's Atlantique multimodal terminal at the Port of Le Havre on France's north coast. The terminal is operated by stevedoring company Compagnie Nouvelle de Manutentions Portuaires Le Havre (CNMP LH). The ...

Highlights The grade control drilling program for the first of two bulk sample sites is now completed (Figure 1), and assays for the first site, 007 North, are reported in Table 1. The initial grade control drilling program commenced on May 5 to define approximately 15,000 tonnes of a planned 45,000-tonne bulk sample program. A total of 68 holes for 623 metres were completed on May 23. Of those holes, 33 were completed at the 007 North site outlining approximately 5,000 tonnes of material. The recent drilli ...

REHOVOT, Israel, June 04, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced a poster presentation on its novel CAPTN-3 tri-specific antibody platform, will be featured at the Annual Congress of the European Association for Cancer Research (EACR) 2025, being held in Lisbon, Portugal from June 16 – 19, 2025. Company Con ...

For more information please refer to AIML's press release dated June 3, 2025: "AIML Subsidiary Neural Cloud Signs LOI with Circular Health to License MaxYield(TM) ECG Signal Processing". About ThreeD Capital Inc. ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD's investment strategy is to invest in multiple private and public companies across a variety of sectors globally. Thr ...

A live webcast of the fireside chat will be available under the "Events" tab on the "Investors" page of the Company's website on the day of the event. A replay of the webcast will be posted on the Company's website following the presentation. WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical- stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Chief Executi ...

Collaboration is designed to implement a highly scalable clinical pathway for Revita in post GLP-1 weight maintenance, pending FDA approval, potentially benefiting millions of eligible patients Rising interest from patients and payers for an off-ramp from GLP-1 drugs is fueling significant demand for endoscopic alternatives designed to restore health rather than manage disease BURLINGTON, Mass. and SAN FRANCISCO, June 04, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), ...

Initial Data from the Ongoing, Blinded Phase 1 Single-Ascending Dose Trial Has Demonstrated Favorable Safety and Pharmacokinetics IND Application Submitted to Expand RESTORE-FA Trial to U.S. Sites; Notice Received from FDA Placing Clinical Hold on IND Application to Open U.S. Sites Forward-Looking Statements "We are pleased by the initial findings from the SAD trial that demonstrated a favorable safety profile for DT- 216P2 and support its advancement in the MAD FA patient trial. We are surprised by FDA's n ...

Gold-level Stevie® Award recognizes Maetzold’s transformative leadership in the healthcare industry, including molecular diagnostics and precision medicine FRIENDSWOOD, Texas, June 04, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its founder, president and chief executive officer Derek Maetzold has been awarded a distinguished Lifetime Achievement Award in the Management: Business Products ...